What causes aplastic anaemia? |
Apr 2023 |
Leukemia |
Aplastic Anemia |
Alternative donor BMT with post-transplant cyclophosphamide as initial therapy for acquired severe aplastic anemia |
Apr 2023 |
Blood |
Aplastic Anemia |
Transplant Referral Patterns for Patients with Newly Diagnosed Higher-Risk Myelodysplastic Syndromes and Acute Myeloid Leukemia at Academic and Community Sites in the Connect® Myeloid Disease Registry: Potential Barriers to Care |
Apr 2023 |
Transplantation and Cellular Therapy |
Myelodysplastic Syndromes (MDS) |
VEXAS syndrome: a new paradigm for adult-onset monogenic autoinflammatory diseases |
Apr 2023 |
Internal and Emergency Medicine |
Myelodysplastic Syndromes (MDS) |
Activity of luspatercept and ESAs combination for treatment of anemia in lower-risk myelodysplastic syndromes |
Apr 2023 |
Blood Advances |
Myelodysplastic Syndromes (MDS) |
PNH and complement gene variants |
Apr 2023 |
Blood |
Paroxysmal Nocturnal Hemoglobinuria (PNH) |
Ipilimumab plus decitabine for patients with MDS or AML in posttransplant or transplant-naïve settings |
Apr 2023 |
Blood |
Myelodysplastic Syndromes (MDS) |
Therapeutic Targets in Myelodysplastic Neoplasms: Beyond Hypomethylating Agents |
Apr 2023 |
Current Hematologic Malignancy Reports |
Myelodysplastic Syndromes (MDS) |
Statin Use in Myelodysplastic Syndromes Is Associated with a Better Survival and Decreased Progression to Leukemia |
Apr 2023 |
Blood Advances |
Myelodysplastic Syndromes (MDS) |
Whole-genome sequencing identifies novel predictors for hematopoietic cell transplant outcomes for patients with myelodysplastic syndrome: a CIBMTR study |
Apr 2023 |
Journal of Hematology & Oncology |
Myelodysplastic Syndromes (MDS) |